1-aminoisoquinoline has been researched along with Chronic Pain in 1 studies
*Chronic Pain: Aching sensation that persists for more than a few months. It may or may not be associated with trauma or disease, and may persist after the initial injury has healed. Its localization, character, and timing are more vague than with acute pain. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alt, J; Aoki, M; Chatrath, S; Dong, X; Hihara, H; Hin, N; Kopajtic, T; Li, Z; Liu, Q; Ng, J; Nishioka, T; Prchalová, E; Rais, R; Rojas, C; Slusher, BS; Suzuki, S; Thomas, AG; Tsukamoto, T; Veeravalli, V; Yoshizawa, K | 1 |
1 other study(ies) available for 1-aminoisoquinoline and Chronic Pain
| Article | Year |
|---|---|
Discovery of Benzamidine- and 1-Aminoisoquinoline-Based Human MAS-Related G-Protein-Coupled Receptor X1 (MRGPRX1) Agonists.
Topics: Analgesics; Animals; Benzamidines; Chronic Pain; Drug Design; HEK293 Cells; Humans; Isoquinolines; Magnetic Resonance Spectroscopy; Male; Mice; Neurons; Receptors, G-Protein-Coupled | 2019 |